Gentofte, Denmark

Sisse Rye Ostrowski

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Endothel Pharma Aps, Rigshospitalet. Active years: 2016-2023.


% Patents Active = 66.7

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Sisse Rye Ostrowski: Innovator in Medical Treatments

Introduction

Sisse Rye Ostrowski is a notable inventor based in Gentofte, Denmark. She has made significant contributions to the field of medicine, particularly in the treatment of critically ill patients. With a total of 3 patents, her work focuses on innovative medical compositions and methods.

Latest Patents

Ostrowski's latest patents include a composition comprising prostacyclin and/or analogues thereof for the treatment of acute critically ill patients. This invention specifically addresses the use of prostacyclin or an analogue for a new medical indication in patients suffering from systemic endothelial damage. Additionally, her patents detail a biomarker for identifying individuals with this new medical indication and a method for identifying such indications.

Career Highlights

Throughout her career, Sisse Rye Ostrowski has worked with prominent organizations such as Endothel Pharma ApS and Rigshospitalet. Her experience in these institutions has allowed her to develop and refine her innovative ideas in medical treatments.

Collaborations

Ostrowski has collaborated with various professionals in her field, including her coworker Pär Ingemar Johansson. Their joint efforts have contributed to advancements in medical research and treatment methodologies.

Conclusion

Sisse Rye Ostrowski's contributions to medical innovation highlight her dedication to improving patient care. Her patents and collaborations reflect her commitment to advancing medical science and addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…